Advertisement

Small Bone Innovations, Inc. (SBi) has announced that Stryker Corporation will acquire substantially all the assets of SBi in an all cash transaction for up to $375 million.

The transaction is expected to close in the third quarter of 2014, subject to customary closing conditions including the expiration or termination of the Hart-Scott-Rodino Antitrust Improvements Act waiting period.

“This transaction is the next step of growth for Small Bone Innovations’ world-class products – especially the STAR Total Ankle – and is a perfect fit with Stryker’s product suite and global reach of its world-class distribution system,” said Michael P. Simpson, President and CEO of SBi.

Piper Jaffray & Co. acted as financial advisor, Herrick, Feinstein LLP acted as lead transaction counsel, Morgan, Lewis & Bockius LLP acted as intellectual property counsel, Norton Rose Fulbright acted as regulatory counsel, and Musculoskeletal Clinical Regulatory Advisers, LLC acted as clinical, regulatory and quality systems advisor.

Advertisement
Advertisement